Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Professor Andrew Briggs

BSc (Hons) MSc DPhil

Professor

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Jump to: Affiliations Research Publications

Affiliations

Faculty of Public Health and Policy
Department of Health Services Research and Policy

Centres

Centre for Evaluation
Statistical Methodology

Research

Research Area
Decision analysis
Economic evaluation
Randomised controlled trials
Discipline
Health economics
Country
United Kingdom
United States
South Africa
Region
European Union
North America
Sub-Saharan Africa (all income levels)

Selected Publications

Application of a Mapping Function to Estimate Utilities for Ragweed Allergy Immunotherapy Trials.
Dick K; Briggs A; Brandi H
2020
PharmacoEconomics - open
Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer Support.
Gumley A; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Beattie L; Bell I; Birchwood M; Briggs A; Bucci S
2020
JMIR research protocols
Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial.
McMeekin N; Geue C; Briggs A; Rombach I; Li HK; Bejon P; McNally M; Atkins BL; Ferguson J; Scarborough M
2020
Wellcome open research
Artificial neural network metamodel for sensitivity analysis in a total hip replacement health economic model
Alam MF; Briggs A
2019
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Perspectives of patients, carers and mental health staff on early warning signs of relapse in psychosis: a qualitative investigation.
Allan S; Bradstreet S; McLeod HJ; Gleeson J; Farhall J; Lambrou M; Clark A; Gumley AI
2019
BJPSYCH OPEN
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A
2019
Health technology assessment
Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons.
Tremblay G; Westley T; Cappelleri JC; Arondekar B; Chan G; Bell TJ; Briggs A
2019
CLINICOECONOMICS AND OUTCOMES RESEARCH
A criterion-based approach to systematic and transparent comparative effectiveness: a case study in psoriatic arthritis.
Tremblay G; Westley T; Forsythe A; Pelletier C; Briggs A
2019
Journal of comparative effectiveness research
See more Publications

Contact

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom